European patent office restores breast cancer gene patent

The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.

If you want to include this story in your blog, copy and paste this formatted text: